secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2023-03-15T23:59:59+00:00
Accession:  0001193125-23-071452
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.07, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Graybug stockholders approve merger with CalciMedica; 14-to-1 reverse split effective Mar 17
--------------------------------------------------------------------------------

- All five proposals approved: share issuance (13.2M for), charter amendment, equity plan, ESPP, and adjournment.
- Reverse stock split ratio set at 14-to-1, effective after market close March 17, 2023.
- Outstanding shares will reduce from ~22M to ~1.57M; no fractional shares—cash in lieu.
- Common stock to trade split-adjusted on Nasdaq under new CUSIP 38942Q 202 starting March 20.
- Merger with CalciMedica remains subject to customary closing conditions; no closing date announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/d481564d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-071452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer